Therapeutic modulation of RNA-binding protein Rbm38 facilitates re-endothelialization after arterial injury
Kristina Sonnenschein(Medizinische Hochschule Hannover), Thomas Thum(Medizinische Hochschule Hannover)
Cited by 15
Related Papers
Baseline Cardiovascular Risk Assessment in Cancer Patients Scheduled to Receive Cardiotoxic Cancer Therapies: A Position Statement and New Risk Assessment Tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in Collaboration with the International Cardio-Oncology Society
|European Journal of Heart Failure|2020|767
Role of Cardiovascular Imaging in Cancer Patients Receiving Cardiotoxic Therapies: A Position Statement on Behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the European Society of Cardiology (ESC)
|European Journal of Heart Failure|2020|364
Gut Microbiota–Dependent Trimethylamine <i>N</i> -Oxide Predicts Risk of Cardiovascular Events in Patients With Stroke and Is Related to Proinflammatory Monocytes
|Arteriosclerosis Thrombosis and Vascular Biology|2018|300
The continuous heart failure spectrum: moving beyond an ejection fraction classification
|European Heart Journal|2019|258